Published in Nephrol Dial Transplant on October 25, 2005
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut (2007) 4.51
Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. Crit Care (2010) 1.14
Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. Int Urol Nephrol (2010) 0.96
Recent advances in our understanding of hepatorenal syndrome. Nat Rev Gastroenterol Hepatol (2012) 0.94
Risk factors for acute kidney injury following orthotopic liver transplantation: the impact of changes in renal function while patients await transplantation. BMC Nephrol (2010) 0.84
Hepatorenal syndrome: Update on diagnosis and treatment. World J Nephrol (2015) 0.84
Predictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction. BMC Nephrol (2013) 0.81
Renal dysfunction in cirrhosis is not just a vasomotor nephropathy. Kidney Int (2014) 0.79
Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary center. Hepatol Int (2010) 0.79
Pathogenetic background for treatment of ascites and hepatorenal syndrome. Hepatol Int (2008) 0.79
Optimal management of hepatorenal syndrome in patients with cirrhosis. Hepat Med (2010) 0.78
Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus. World J Hepatol (2016) 0.76
Acute Kidney Injury in Patients with Cirrhosis. J Clin Transl Hepatol (2015) 0.75
Hepatorenal syndrome: aetiology, diagnosis, and treatment. Gastroenterol Res Pract (2015) 0.75
Simultaneous Liver-Kidney Transplantation. Curr Transplant Rep (2015) 0.75
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med (1992) 20.79
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54
Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (1988) 4.32
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology (1993) 3.28
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology (2002) 2.56
The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med (2003) 2.46
Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center. Am J Gastroenterol (2002) 2.10
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology (2002) 2.06
Hepatorenal syndrome. Lancet (2003) 1.86
Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med (1973) 1.85
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol (2004) 1.82
Impact of pretransplant renal function on survival after liver transplantation. Transplantation (1995) 1.58
Alcohol abuse: potential role in electrolyte disturbances and kidney diseases. Clin Nephrol (1998) 1.54
Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol (2003) 1.36
Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut (2003) 1.32
Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients. Transplantation (1991) 1.18
Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis (2003) 1.12
Combined liver-kidney transplantation: what are the indications? Transplantation (1997) 1.00
Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol (1997) 0.97
Hepatorenal syndrome in patients with cirrhosis. J Gastroenterol Hepatol (2002) 0.94
Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation (1997) 0.86
Our experience with combined liver-kidney transplantation: an update. Transplant Proc (2002) 0.85
Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci (2003) 0.84
The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Ren Fail (2004) 0.82
Ethanol--its nephrotoxic effect in the rat. Am J Pathol (1977) 0.81
Review article: prognosis of hepatorenal syndrome--has it changed with current practice? Aliment Pharmacol Ther (2004) 0.80
Alcohol: its effect on the kidney. Adv Exp Med Biol (1977) 0.80
Effect of acute and chronic ethanol treatment on renal prostaglandins in the rat. Alcohol (1986) 0.80
Hepatorenal syndrome. Ann Hepatol (2004) 0.79
Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome. Eur J Gastroenterol Hepatol (2003) 0.78
Selection and preparation of candidates for combined liver-kidney transplantation: experience at a single center-two case reports. Transplant Proc (2004) 0.77
Production of alpha 1,3-galactosyltransferase-deficient pigs. Science (2002) 3.96
Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol (2006) 3.07
VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surg Forum (1983) 2.30
THE USE OF COMBINED PRESERVATION TECHNIQUES FOR EXTENDED STORAGE OF ORTHOTOPIC LIVER HOMOGRAFTS. Surg Gynecol Obstet (1968) 2.20
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93
The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med (2005) 1.75
Complications of right lobe living donor liver transplantation. J Hepatol (2009) 1.73
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61
EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. Surg Forum (1986) 1.59
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci U S A (2006) 1.46
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42
SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21
Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18
OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11
Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg (2005) 1.10
Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol (2008) 1.04
Humoral Antibodies in Patients After Renal Homotransplantation. Transplantation (1967) 0.96
Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant (2005) 0.95
Human dominant-negative class II transactivator transgenic pigs - effect on the human anti-pig T-cell immune response and immune status. Immunology (2013) 0.95
Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant (1990) 0.94
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation (2004) 0.91
Tacrolimus (FK506)-Associated Renal Pathology. Adv Anat Pathol (1997) 0.90
Venom proteomic characterization and relative antivenom neutralization of two medically important Pakistani elapid snakes (Bungarus sindanus and Naja naja). J Proteomics (2013) 0.90
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol (2003) 0.89
Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med (2008) 0.88
Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol (2002) 0.88
ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. Clin Transplant (1988) 0.87
The treatment of penetrating wounds of the inferior vena cava. Surgery (1962) 0.86
Screening for parathyroid hormone resistance in patients with nonphenotypically evident pseudohypoparathyroidism. Endocr Pract (2012) 0.86
Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells. J Cell Physiol (2010) 0.85
Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. Blood (2006) 0.82
Smooth muscle tumor arising de novo in a liver allograft: A case report. Clin Transplant (1991) 0.82
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation (2006) 0.82
Interval timing and trajectory in unequal amplitude movements. Exp Brain Res (2008) 0.82
Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation (2002) 0.81
Pancreatic transplantation at the University of Pittsburgh. Clin Transpl (2004) 0.81
Hepatic artery thrombosis following pediatric liver transplantation: Assessment of blood flow measurement in allografts. Clin Transplant (1989) 0.81
Reported toxicity in 1486 liquid detergent capsule exposures to the UK National Poisons Information Service 2009-2012, including their ophthalmic and CNS effects. Clin Toxicol (Phila) (2013) 0.81
Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplant (1992) 0.80
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Tolerance for organ recipients: a clash of paradigms. Liver Transpl (2006) 0.78
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. Transplant Sci (1993) 0.78
Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients. Pediatr Transplant (2006) 0.78
Kidney after nonrenal transplantation-the impact of alemtuzumab induction. Transplantation (2009) 0.78
Cadaveric renal transplantation using kidneys from donors greater than 60 years old. Clin Transplant (1992) 0.78
Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells. Transplant Sci (1992) 0.78
Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl (2008) 0.78
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. Transplantation (2007) 0.78
LIVER TRANSPLANTATION IN MAN. Ann N Y Acad Sci (1970) 0.78
The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts. Transplantation (2006) 0.78
Pheochromocytoma causing cardiomyopathy, ischemic stroke and acute arterial thrombosis: a case report and review of the literature. Conn Med (2013) 0.77
Kidney/Bone Marrow Transplantation. Dial Transplant (1996) 0.76
Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin Transplant (1993) 0.75
World's longest surviving liver-pancreas recipient. Liver Transpl (2007) 0.75
Stalking study: scary. J Psychosoc Nurs Ment Health Serv (2008) 0.75
Transplantation. JAMA (1986) 0.75
Effect of homograft ischemia upon serum proteins after orthotopic liver transplantation. Surgery (1968) 0.75
Cold heparinized lactated Ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations. Transplantation (2007) 0.75
Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. Kusuri No Chishiki (1995) 0.75
Prevention of Transplant Rejection: Can Tolerance be Achieved with Immunosuppressive Treatment? Clin Immunother (1996) 0.75
Blood Vessel Bank: Organization and Function. Bull Univ Miami Sch Med Jackson Meml Hosp (1957) 0.75
Successful salvage of mucormycosis infection of the forearm and osteomyelitis of the ulna. Hand (N Y) (2008) 0.75
Hepatic Regeneration. Viewp Dig Dis (1979) 0.75
LONG TERM RESULTS OF HEPATIC TRANSPLANTATION DURING THE CYCLOSPORINE ERA: THE PITTSBURGH EXPERIENCE. Transplant Clin Immunol (1987) 0.75
Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction. Transplantation (2008) 0.75
The Problem of Frostbite in Civilian Medical Practice. Surg Clin North Am (1963) 0.75
Pancreatic complications following orthotopic liver transplantation. Clin Transplant (1992) 0.75
CRITICAL CARE MEDICINE AND LIVER TRANSPLANTATION. Crit Care (1985) 0.75
Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation (1997) 0.75
Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants. Clin Transplant (1987) 0.75
On the crossroad between tolerance and posttransplant lymphoma. Curr Opin Organ Transplant (1997) 0.75
Causes of death after liver transplantation in children treated with cyclosporine and steroids. Clin Transplant (1989) 0.75
Transplant innovation and ethical challenges: what have we learned? A collection of perspectives and panel discussion. Cleve Clin J Med (2008) 0.75
Fifty years later. Clin Transpl (2013) 0.75
Recurrent liver disease after liver transplantation. Forum (Genova) (1997) 0.75
Proteomic comparison of Hypnale hypnale (hump-nosed pit-viper) and Calloselasma rhodostoma (Malayan pit-viper) venoms. J Proteomics (2013) 0.75